Home › SEC Filings › Insider Cluster Activity
Insider Cluster Activity
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| ABBV | CLUSTER | bearish | 6/10 | Two AbbVie executives, SVP and EVP, each sold shares in the open market, totaling approximately $2.57 million in proceed | Mar 6, 2026 |
| GENB | CLUSTER | bullish | 7/10 | Generate Biomedicines CEO Michael Nally led a $240,000 open-market share purchase, joined by three other executives in s | Mar 6, 2026 |
| QURE | CLUSTER | bearish | 7/10 | Multiple C-suite executives at uniQure N.V. sold shares in a coordinated open-market transaction on March 2, 2026, total | Mar 6, 2026 |
| ZLAB | CLUSTER | neutral | 3/10 | A recent insider trading cluster at Zai Lab includes open-market sales by the Chief Legal Officer and a board member, al | Mar 6, 2026 |
| PEPG | CLUSTER | neutral | 3/10 | PepGen insiders executed a mix of open-market sales and non-cash award grants. CEO and CFO sold a combined $44.7K in sha | Mar 6, 2026 |
| ALNY | CLUSTER | neutral | 3/10 | Seven Alnylam Pharmaceuticals insiders executed trades over the past week, with three C-suite executives selling a combi | Mar 6, 2026 |
| DYN | CLUSTER | neutral | 3/10 | Two top executives at Dyne Therapeutics, the CEO and Chief Medical Officer, sold shares in a coordinated open-market tra | Mar 6, 2026 |
| VRTX | CLUSTER | neutral | 4/10 | Two Vertex Pharmaceuticals EVPs, the Chief Commercial Officer and Chief Legal Officer, sold shares in open-market transa | Mar 6, 2026 |
| LONA | CLUSTER | neutral | 3/10 | LeonaBio's entire C-suite, including the CEO, CFO, CMO, and CSO, sold shares in the open market on March 4, 2026, immedi | Mar 5, 2026 |
| LONA | CLUSTER | neutral | 3/10 | Three C-suite executives at LeonaBio, the Chief Scientific Officer, CFO, and Chief Medical Officer, sold shares in the o | Mar 5, 2026 |
| GLUE | CLUSTER | neutral | 3/10 | Monte Rosa Therapeutics CEO Markus Warmuth and Principal Accounting Officer Edmund Dunn sold shares in a recent cluster | Mar 5, 2026 |
| UTHR | CLUSTER | neutral | 4/10 | A recent insider trading cluster at United Therapeutics shows CEO Martine Rothblatt exercising options for nearly $2.8M | Mar 5, 2026 |
| PACB | CLUSTER | neutral | 3/10 | A cluster of insider transactions at Pacific Biosciences of California (PACB) over the past week consists primarily of n | Mar 5, 2026 |
| FBLG | CLUSTER | bullish | 6/10 | Multiple C-suite executives at FibroBiologics, including the CEO, CFO, and Chief Scientific Officer, collectively purcha | Mar 5, 2026 |
| ALKS | CLUSTER | neutral | 3/10 | Three executives at Alkermes sold shares in the past week, including two open-market sales by EVPs Gaffin and Parisi tot | Mar 4, 2026 |
| ALNY | CLUSTER | neutral | 3/10 | A cluster of insider transactions at Alnylam Pharmaceuticals over the past week includes open-market sales by the CSO an | Mar 4, 2026 |
| ANNX | CLUSTER | neutral | 3/10 | Five executive officers at Annexon, Inc. (ANNX) sold shares in a coordinated open-market transaction on March 2, 2026, r | Mar 4, 2026 |
| ATRA | CLUSTER | neutral | 2/10 | Two insiders at Atara Biotherapeutics sold shares in the past week, including CEO AnhCo Nguyen who sold 198 shares for $ | Mar 4, 2026 |
| QURE | CLUSTER | neutral | 3/10 | Chief Medical Officer Walid Abi-Saab sold 1,660 shares of QURE in the open market for $16,517. This is a small, routine | Mar 4, 2026 |
| JAZZ | CLUSTER | neutral | 4/10 | Jazz Pharmaceuticals insiders executed a mix of open-market sales and non-cash equity transactions over the past week. C | Mar 4, 2026 |
| VRTX | CLUSTER | bearish | 6/10 | Three senior executives at Vertex Pharmaceuticals, including the CEO and two EVPs, sold shares in a coordinated 7-day wi | Mar 4, 2026 |
| ARQT | CLUSTER | bearish | 6/10 | Multiple insiders at Arcutis Biotherapeutics sold shares in a coordinated open-market cluster totaling $1.65M over two d | Mar 4, 2026 |
| VCEL | CLUSTER | neutral | 4/10 | Two Vericel Corp executives, the Chief Legal Officer and Chief Operating Officer, sold shares in the open market, totali | Mar 4, 2026 |
| AMLX | CLUSTER | bearish | 7/10 | Five senior executives at Amylyx Pharmaceuticals, including both Co-CEOs, the CFO, CMO, and Chief Legal Officer, collect | Mar 4, 2026 |
| ARQT | CLUSTER | neutral | 4/10 | Multiple executives at Arcutis Biotherapeutics sold shares in a coordinated open-market transaction totaling $1.3M acros | Mar 3, 2026 |
| ABT | CLUSTER | neutral | 3/10 | A cluster of insider transactions at Abbott Laboratories over the past week includes open-market sales by two executives | Mar 3, 2026 |
| RARE | CLUSTER | bearish | 5/10 | Multiple executives at Ultragenyx Pharmaceutical, including the CFO and Chief Medical Officer, conducted open-market sha | Mar 3, 2026 |
| KRYS | CLUSTER | neutral | 5/10 | Krystal Biotech insiders executed a cluster of trades over the past week, including open-market sales totaling $4.4 mill | Mar 3, 2026 |
| ALEC | CLUSTER | bearish | 5/10 | Multiple C-suite executives at Alector, Inc. (ALEC) sold shares in the past week, including CEO Arnon Rosenthal and CFO | Mar 3, 2026 |
| UTHR | CLUSTER | neutral | 3/10 | A recent insider trading cluster at United Therapeutics includes two open-market share sales totaling $127K and two deri | Mar 3, 2026 |